資料載入處理中...
臺灣人文及社會科學引文索引資料庫系統
:::
網站導覽
國圖首頁
聯絡我們
操作說明
English
行動版
(3.15.12.231)
登入
字型:
**字體大小變更功能,需開啟瀏覽器的JAVASCRIPT,如您的瀏覽器不支援,
IE6請利用鍵盤按住ALT鍵 + V → X → (G)最大(L)較大(M)中(S)較小(A)小,來選擇適合您的文字大小,
如為IE7以上、Firefoxy或Chrome瀏覽器則可利用鍵盤 Ctrl + (+)放大 (-)縮小來改變字型大小。
來源文獻查詢
引文查詢
瀏覽查詢
作者權威檔
引用/點閱統計
我的研究室
資料庫說明
相關網站
來源文獻查詢
/
簡易查詢
/
查詢結果列表
/
詳目列表
:::
詳目顯示
第 1 筆 / 總合 1 筆
/1
頁
來源文獻資料
摘要
外文摘要
引文資料
題名:
加速失敗時間模式分析新發乳癌病患併發血栓栓塞對其存活的影響
書刊名:
臺灣公共衛生雜誌
作者:
王南天
/
蘇慧芳
/
李佩珍
/
張正雄
/
林寬佳
/
謝碧晴
作者(外文):
Wang, Nan-ten
/
Su, Hui-fang
/
Lee, Pei-chen
/
Chang, Cheng-shyong
/
Lin, Kuan-chia
/
Hsieh, Pi-ching
出版日期:
2014
卷期:
33:6
頁次:
頁582-596
主題關鍵詞:
血栓栓塞
;
存活
;
加速失敗時間模型
;
Thromboembolic events
;
Survival
;
Accelerated failure time model
原始連結:
連回原系統網址
相關次數:
被引用次數:期刊(0) 博士論文(0) 專書(0) 專書論文(0)
排除自我引用:0
共同引用:
2
點閱:31
目標:血栓栓塞併發症(TEEs)為乳癌併發症主要之一且增加死亡風險,本研究擬探討台灣新發乳癌病患併發血栓栓塞之相關因素及對其兩年存活的影響。方法:本回溯性世代研究使用1997至2010年全民健康保險研究資料庫。以Poisson分佈探討2000到2008年新發乳癌世代觀察兩年其併發TEEs的發生情形。透過propensity socre匹配後再以Accelerated Failure Time Model檢視有無併發症病患對其兩年存活之影響。結果:2000-2008年新發乳癌世代共80,598人,罹癌確診後兩年內併發TEEs之累積發生率1.78%(95% CI = 1.74-1.82),且第一個半年併發症發生密度為1.38發生事件數/每100個人年。併發TEEs危險因子有年齡(≧65歲比<45歲adjusted incidence rate ratio [adj. IRR] = 3.87,95% CI = 3.80-3.93),共病指數(≧3分比0分adj. IRR = 1.96,95% CI = 1.93-2.00),有高血壓病史(adj. IRR = 1.43,95% CI = 1.41-1.45),有乳房手術者(adj. IRR = 1.47,95% CI = 1.45-1.49),接受放射線治療者(adj. IRR = 1.29,95% CI = 1.28-1.31),接受化學藥物治療者(adj. IRR = 1.40,95% CI = 1.38-1.42),醫院層級(地區醫院比醫學中心adj. IRR = 1.13,95% CI = 1.11-1.15)。AFT model分析顯示在控制其他變項後,有併發TEEs者比無者有較高比例的兩年死亡風險(adjusted Rate Ratio = 2.55, 95% CI = 2.24-2.91),且風險隨時間增加而增加。結論:新發乳癌病患併發TEEs會增加其死亡風險。醫療專業人員者可針對易併發TEE之危險群(如年長、共病指數高、有高血壓、接受乳癌手術、接受化療放療),即早警覺並提供適當的預防措施以利降低併發症的發生及提升癌症照護品質。
以文找文
Objectives: Thromboembolic events (TEEs) are major complications affecting breast cancer patients, and are associated with increased mortality. The purpose of this study was to determine the incidence and risk factors for developing a new TEE in a population-based cohort of breast cancer patients, and also to determine the effect of TEEs on 2-year survival. Methods: A retrospective cohort study was conducted between 1997-2010 using the National Health Insurance Research Database in Taiwan. The incidence of TEEs amongst 2000-2008 breast cancer cohorts and the associated risk factors were determined based on the Poisson distribution. Propensity score matching was used to determine the effect of TEEs on 2-year survival through accelerated failure-time (AFT) model analysis. Results: Amongst 80,598 patients with breast cancer between 2000 and 2008, the 2-year cumulative TEE incidence was 1.78%, with a rate of 1.38 events/100 patient-years during the first 6 months. Based on a multivariate model, significant predictors of developing TEEs within 2 years were age (adjusted incidence rate ratio [aIRR] = 3.87 if ≧ 65 years vs. <45 years; 95% CI = 3.80-3.93), co-morbidity (aIRR = 1.96 if ≧3 vs. 0, 95% CI = 1.93-2.00), hypertension (aIRR = 1.43 if yes vs. no, 95% CI = 1.41-1.45), history of breast surgery (aIRR = 1.47 if yes vs. no, 95% CI = 1.45-1.49), history of radiotherapy (aIRR = 1.29 if yes vs. no, 95% CI = 1.28-1.31), history of chemotherapy (aIRR = 1.40 if yes vs. no, 95% CI = 1.38-1.42), and type of hospital (aIRR = 1.13 if district medical center vs. patient medical center 95% CI = 1.11-1.15). Based on AFT model analysis, and after controlling for other variables, patients with TEEs had a higher risk of 2-year death than those without TEEs (aRR = 2.55, 95% CI = 2.24-2.91) and had an increased hazard ratio over time. Conclusions: Breast cancer patients with TEEs have a higher risk of death. Early detection of risk factors of TEEs, such as older age, more co-morbidities, hypertension, and histories of surgery, chemotherapy, and radiotherapy) and appropriate preventive care should be provided by health professionals for decreasing the complications and improving the quality of cancer care.
以文找文
期刊論文
1.
Caine, G. J.、Stonelake, P. S.、Rea, D.、Lip, G. Y.(2003)。Coagulopathic complications in breast cancer。Cancer,98,1578-1586。
2.
Chew, H. K.、Wun, T.、Harvey, D. J.、Zhou, H.、White, R. H.(2007)。Incidence of venous thromboembolism and the impact on survival in breast cancer patients。J Clin Oncol,25,70-76。
3.
Khorana, A. A.、Francis, C. W.、Culakova, E.、Kuderer, N. M.、Lyman, G. H.(2007)。Frequency, risk factors, and trends for venous thromboembolism among hospitalized cancer patients。Cancer,110,2339-2346。
4.
Rickles, F. R.、Edwards, R. L.、Barb, C.、Cronlund, M.(1983)。Abnormalities of blood coagulation in patients with cancer. Fibrinopeptide A generation andtumorgrowth。Cancer,51,301-307。
5.
McDonald, C. C.、Alexander, F. E.、Whyte, B. W.、Forrest, A. P.、Stewart, H. J.(1995)。Cardiac and vascular morbidity in women receiving adjuvant tamoxifen for breast cancer in a randomized trial。BMJ,311,977-980。
6.
Andtbacka, H. I.、Babiera, G.、Singletary, S. E.(2006)。Incidence and prevention of venous thromboembolism in patients undergoing breast cancer surgery and treated according to clinical pathways。Ann Surg,243,96-101。
7.
Chavez-MacGregor, M.、Zhao, H.、Kroll, M.(2011)。Risk factors and incidence of thromboembolic events (TEEs) in older men and women with breast cancer。Ann Oncol,22,2394-2402。
8.
Hooning, M. J.、Dorresteijn, D. A.、Aleman, M. P.(2006)。Decreased risk of stroke among 10-year survivors of breast cancer。J Clin Oncol,24,5388-5394。
9.
Khorana, A. A.、Francis, C. W.、Culakova, E.、Fisher, R. I.、Kuderer, N. M.、Lyman, G. H.(2006)。Thromboembolism in hospitalized neutropenic cancer patients。J Clin Oncol,24,484-490。
10.
梁逸歆、徐志宏(20110200)。Pulmonary Thromboembolism Related to Progression of Duodenal Adenocarcinoma。臺灣癌症醫學雜誌,27(1),37-41。
延伸查詢
11.
王智慧、張君照、戴承正(20110800)。Deep Venous Thrombosis and Pulmonary Embolism in Pancreatic Cancer。臺灣癌症醫學雜誌,27(4),171-176。
延伸查詢
12.
Ay, C.、Dunkler, D.、Marosi, C.(2010)。Prediction of venous thromboembolism in cancer patients。Blood,116,5377-5382。
13.
Nolan, L.、Darby, A.、Boleti, K.、Simmonds, P.(2011)。The incidence of symptomatic thromboembolism in patients receiving adjuvant anthracycline-based chemotherapy for early stage breast cancer。Breast,20,151-154。
14.
Cushman, M.、Tsai, A. W.、White, R. H.(2004)。Deep vein thrombosis and pulmonary embolism in two cohorts: the longitudinal investigation of thromboembolism etiology。Am J Med,117,19-25。
15.
Khorana, A. A.、Francis, C. W.、Culakova, E.、Lyman, G. H.(2005)。Risk factors for chemotherapy-associated venous thromboembolism in a prospective observational study。Cancer,104,2822-2829。
16.
Lyman, G. H.、Khorana, A. A.、Falanga, A.(2007)。American Society of Clinical Oncology guideline: recommendations for venous thromboembolism prophylaxis and treatment in patients with cancer。J Clin Oncol,25,5490-5505。
17.
Heit, J. A.、Silverstein, M. D.、Mohr, D. N.、Petterson, T. M.、O'Fallon, W. M.、Melton, L. J.(2000)。Risk factors for deep vein thrombosis and pulmonary embolism a population-based case-control study。Arch Intern Med,160,809-815。
18.
Heit, J. A.、O'Fallon, W. M.、Patterson, T. M.(2002)。Relative impact of risk factors for deep vein thrombosis and pulmonary embolism。Arch Intern Med,162,1245-1248。
19.
Deitcher, S. R.、Gomes, M. P. V.(2004)。The risk of venous thromboembolic disease associated with adjuvant hormone therapy for breast carcinoma。Cancer,101,439-449。
20.
Kyriazi, V.(2012)。Breast cancer as an acquired thrombophilic state。J Breast Cancer,15,148-156。
21.
Baum, M.、Budzar, A. U.、Cuzick, J.(2002)。Anastrozole alone or in combination with tamoxifen versus tamoxifen alone for adjuvant treatment of postmenopausal women with early breast cancer: first results of the ATAC randomised trial。Lancet,359,2131-2139。
22.
陳錫杰、蘇慧芳、李中一、賴美淑、謝碧晴(20100400)。醫師的遵循行為可促進病患的存活嗎?以臺灣非小細胞肺癌病患為例。臺灣公共衛生雜誌,29(2),118-130。
延伸查詢
圖書
1.
衛生福利部國民健康署(2012)。民國98年癌症登記報告。臺北:衛生福利部國民健康署。
延伸查詢
2.
Allison, P. D.(2004)。Survival Analysis Using SAS®: A Practical Guide。North Carolina:SAS Institute Inc.。
其他
1.
臺灣癌症登記中心。長期趨勢,http://tcr.cph.ntu.edu.tw/, 2014/06/29。
延伸查詢
2.
衛生福利部。民國101死因統計年報,http://www.mohw.gov.tw/cht/DOS/DisplayStatisticFile.aspx?d=13718&s=1, 2014/06/29。
3.
The Joint Commission。Core measure sets,http://www.jointcommission.org/core_measure_sets.aspx, 2013/05/24。
4.
衛生福利部中央健保署(2011)。2011年全民健康保險統計動向,http://www.nhi.gov.tw/resource/Webdata/23838_1_%E5%85%A8%E6%B0%91%E5%81%A5%E5%BA%B7%E4%BF%9D%E9%9A%AA%E7%B5%B1%E8%A8%88%E5%8B%95%E5%90%91-2011%E5%B9%B4.pdf, 2013/06/20。
推文
當script無法執行時可按︰
推文
推薦
當script無法執行時可按︰
推薦
引用網址
當script無法執行時可按︰
引用網址
引用嵌入語法
當script無法執行時可按︰
引用嵌入語法
轉寄
當script無法執行時可按︰
轉寄
top
:::
相關期刊
相關論文
相關專書
相關著作
熱門點閱
1.
提昇非小細胞肺癌病人手術後接受輔助性治療率之專案
2.
以類神經網路及分類迴歸樹輔助肝癌病患預測存活情形
3.
醫師的遵循行為可促進病患的存活嗎?以臺灣非小細胞肺癌病患為例
無相關博士論文
無相關書籍
無相關著作
1.
大學生正負向完美主義、心流傾向與心理幸福感之結構方程模式分析
2.
電腦自我效能影響因素之實證文獻分析
3.
臺灣新生兒B型肝炎疫苗政策之直接成本分析
4.
資訊科技應用於改善多重慢性病人門診重複處方之分析
5.
健康行為群聚類別與醫療利用之關係--以臺灣成年初顯期族群為例
6.
身體質量指數及日常運動預防臺灣中老年人步行能力衰退之組合效應
7.
乳癌病患使用部落格的疾病經驗交流之初探
8.
臺灣營養師工作壓力、工作滿意度、職業倦怠和離職傾向之現況與相關性
9.
醫院非醫務活動收益之分析--以臺灣非營利醫院為例
10.
老人群體居住安排變動與醫療服務使用之多面向長期研究
11.
高雄市石化氣爆災害對登革熱疫情之影響評析
12.
資訊科技涉入度與學習成效之探討--以資訊科技採用意圖為中介變數
13.
擴增實境技術應用於互動式展覽
14.
基植於NFC系統之匿名行動付款協定
15.
SWOT Matrix Enhancement for Online Protection of Personal Information
QR Code